Skip to main content
. 2019 Dec 8;7(1):59–68. doi: 10.1002/acn3.50961

Figure 1.

Figure 1

The effect of STN‐DBS and GPi‐DBS on the UDysRS scores and drug‐off UPDRS‐Ⅲ score in 43 patients with LID. (A) UDysRS scores of patients with STN‐DBS and GPi‐DBS at baseline and the last follow‐up. (B) The comparison of efficacy for clinical improvement of UDysRS between STN‐DBS and GPi‐DBS. (C) Drug‐off UPDRS‐Ⅲ scores of patients with STN‐DBS and GPi‐DBS at baseline and the last follow‐up. (D) The comparison of efficacy for the clinical improvement of drug‐off UPDRS‐Ⅲ between STN‐DBS and GPi‐DBS. "**" indicates P < 0.01. ns, non‐significant; DBS, deep brain stimulation; GPi, globus pallidus interna; STN, subthalamic nucleus; UDysRS, Unified Dyskinesia Rating Scale; UPDRS‐Ⅲ, Unified Parkinson Disease Rating Scale part Ⅲ.